TR201821114A2 - Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m - Google Patents

Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m Download PDF

Info

Publication number
TR201821114A2
TR201821114A2 TR2018/21114A TR201821114A TR201821114A2 TR 201821114 A2 TR201821114 A2 TR 201821114A2 TR 2018/21114 A TR2018/21114 A TR 2018/21114A TR 201821114 A TR201821114 A TR 201821114A TR 201821114 A2 TR201821114 A2 TR 201821114A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
efervescent
erdostein
effervescent
erdosteine
Prior art date
Application number
TR2018/21114A
Other languages
English (en)
Inventor
Koç Erhan
Aktaş Tolga
Original Assignee
Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi
Publication of TR201821114A2 publication Critical patent/TR201821114A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Buluş, aktif etken madde olarak Erdostein ve / veya Erdostein?in farmasötik açıdan kabul edilebilir tuzları, esterleri, polimorfları, solvatları, enanatiomerleri ve / veya türevleri, 5 en az bir efervesan asit-baz çifti ve en az bir yardımcı madde içeren efervesan farmasötik bileşim ile ilgilidir.
TR2018/21114A 2017-12-31 2018-12-30 Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m TR201821114A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17020598.3A EP3505164A1 (en) 2017-12-31 2017-12-31 An effervescent composition comprising erdosteine

Publications (1)

Publication Number Publication Date
TR201821114A2 true TR201821114A2 (tr) 2019-07-22

Family

ID=61258113

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/21114A TR201821114A2 (tr) 2017-12-31 2018-12-30 Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m

Country Status (2)

Country Link
EP (1) EP3505164A1 (tr)
TR (1) TR201821114A2 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4045008A4 (en) * 2019-10-17 2023-11-15 ISP Investments LLC STABLE CO-PROCESSED EFFORTABLE CARRIER COMPOSITION AND METHOD FOR PRODUCING THE SAME
IT202000016816A1 (it) * 2020-07-10 2022-01-10 Edmond Pharma Srl Composizioni comprendenti composti antiossidanti come coadiuvanti nel trattamento di infezioni virali

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA963591B (en) * 1995-05-10 1996-11-19 Adcock Ingram Ltd Pharmaceutical composition
CN101181274A (zh) * 2007-11-27 2008-05-21 北京润德康医药技术有限公司 一种以头孢克肟和厄多司坦为活性成分的药用组合物及其制备方法、用途
CN101199519A (zh) * 2007-11-30 2008-06-18 北京润德康医药技术有限公司 含有环己西林或其衍生物的组合物及其制备方法
CN101214245A (zh) * 2008-01-09 2008-07-09 北京润德康医药技术有限公司 含有环己西林或其衍生物的组合物及其制备方法
CN101612154A (zh) * 2008-06-23 2009-12-30 广东肇庆星湖生物科技股份有限公司 含有匹氨西林的组合物及制备方法、用途

Also Published As

Publication number Publication date
EP3505164A1 (en) 2019-07-03

Similar Documents

Publication Publication Date Title
DOP2025000288A (es) Tetrahidrofuranos sustituidos como moduladores de canales de sodio
MX2020005063A (es) Inhibidores de kras g12c.
CO2020000145A2 (es) Carboxamidas como moduladores de los canales de sodio
MX2021014509A (es) Composiciones farmaceuticas que comprenden meloxicam.
MX2021002428A (es) Combinaciones para tratamiento de ehna/ehgna y enfermedades relacionadas.
MX2021003230A (es) Composiciones farmaceuticas que comprenden meloxicam.
CL2019001993A1 (es) Inhibidores selectivos de jak1.
CY1121554T1 (el) Παραγωγο πυρανοχρωμενυλ-φαινολης, και φαρμακευτικη συνθεση για αγωγη μεταβολικου συνδρομου ή φλεγμονωδους παθησης
MA38399A1 (fr) Formulation sous forme de comprimé, utile pour traiter l'insuffisance cardiaque aiguë et l'insuffisance cardiaque chronique
MX2017014994A (es) Formulacion solida oral que contiene irinotecano y metodo de preparacion de la misma.
BR112018009534A2 (pt) composição farmacêutica contendo 2-{4-[n-(5,6-difenilpirazin-2-il)-n-isopropilamino]butiloxi }-n-(metilsulfonil)acetamida
CY1117881T1 (el) Στερεες φαρμακευτικες συνθεσεις που περιλαμβανουν παραγωγα βιοπτερινης και χρησεις αυτων των συνθεσεων
PL3773735T3 (pl) Koniugat leku cytotoksycznego i postać proleku koniugatu
MX379253B (es) Formulaciones de oximetazolina estabilizadas y sus usos.
TR201821114A2 (tr) Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
MX391191B (es) Composiciones de liberación extendida de onapristona y métodos.
UA116499C2 (uk) (r)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
MX390441B (es) Formulaciones liquidas de fosfaplatino.
MX381515B (es) Composición farmacéutica que comprende nebivolol con tasa de disolución mejorada
TR201815617A2 (tr) Deksketoprofen içeren bir formülasyon.
BR112017014295A2 (pt) composição farmacêutica.
TR201821115A2 (tr) Montelukast ve levoseti̇ri̇zi̇n i̇çeren farmasöti̇k bi̇leşi̇m
TR201722630A2 (tr)
TR201910633A1 (tr) Si̇taglipti̇n i̇çeren efervesan tablet kompozi̇syonu